DSE-FRET: A new anticancer drug screening assay for DNA binding proteins. - sprookjes - yvandenbroek - TriplyDB

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

http://www.wikidata.org/entity/Q35051906

about

Recent advances in transcription factor assays in vitro.Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS.

P2860

Q38753507-83BE9F3A-CD24-4994-82D1-4F047FE80E34 Q38847849-B47FD37D-AB17-496E-BD2C-142CB6870E65

P2860

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

http://www.wikidata.org/entity/Q35051906

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@ast

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@en

type

label

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@ast

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@en

prefLabel

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@ast

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@en

P1433

Q35051906-065E4064-C1C1-4A84-86C0-D394569F1481

P1476

Q35051906-488B2395-8834-4712-BF53-DD3F7A325250

P2093

Q35051906-06A58203-5271-4FAE-90F8-B73689C0E85F

Q35051906-1208D665-AD23-430D-92B2-1D3DE7430E14

Q35051906-3139DF8B-22A2-431B-AFF4-ED757D2D1B5A

Q35051906-55080DB3-C4CC-4C56-88B6-375D8B00007C

Q35051906-750EA837-F79C-484D-82E6-E01F4C0A4492

Q35051906-95B2F8D7-CE2C-4421-8587-AEE63B9F40F0

Q35051906-96B4FB61-B64E-45DF-8489-58E4BCCCD118

Q35051906-B6E65634-3117-4B36-9821-C8FCFC2C4B3C

Q35051906-C4DE8962-91B4-4B6F-9F8D-01310CE96141

P2860

Q35051906-05D93320-EA20-4041-932A-174C4906C3EA

Q35051906-28F5DFC4-4569-43B4-B223-1FD82CBC59B7

Q35051906-2A71BFA3-8467-4C7F-A21D-F4D7554B9741

Q35051906-2ABBF6CC-8574-4AE2-96D8-EC5EF33018AC

Q35051906-3354CCDD-588D-47EB-8C97-5CF94A923D0C

Q35051906-38B67D41-5179-4440-B5BD-16FA7A074502

Q35051906-3CEDCC69-F62E-400D-8FF4-7BC839F7AFB9

Q35051906-3E6665B6-B6F4-4339-A20E-1532EBB2A216

Q35051906-654674A0-B93C-41C9-8BDF-715E77F56712

Q35051906-90EA09E9-E9BD-4D98-AA43-EB65E7D80E57

P304

Q35051906-5C19718E-423A-44FA-8E77-567B3E8443B6

P31

Q35051906-02406E75-3575-4ABB-B611-781B7EB5FB09

P356

Q35051906-5329B9B1-3213-43E6-A256-70C6BC493EB5

P433

Q35051906-AC34F593-EB6C-4ACE-B946-278E54B7C060

P478

Q35051906-FBF328B4-97DA-4A86-8196-130BE3964D32

P577

Q35051906-4AAAC5D2-ACFC-4039-B372-A12C4AB1D4B0

P5875

Q35051906-4FE405FC-C984-4C3F-9D79-811FB66837C7

P698

Q35051906-8037DB3F-7076-4F90-9A78-AD2BB3511022

P921

Q35051906-9C67E6F4-0E1C-4BA6-83B9-75D2C6DD48CD

P932

Q35051906-E32D538C-CCA9-4F89-9D43-4D0F64380604

P356

P1433

P1476

DSE-FRET: A new anticancer drug screening assay for DNA binding proteins.

@en

P2093

Bunsyo Shiotani

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Tahara

http://www.w3.org/2001/XMLSchema#string

Kazuo Umezawa

http://www.w3.org/2001/XMLSchema#string

Mikihisa Takano

http://www.w3.org/2001/XMLSchema#string

Ryuya Miyoshi

http://www.w3.org/2001/XMLSchema#string

Takahiro Ochiya

http://www.w3.org/2001/XMLSchema#string

Takanori Oka

http://www.w3.org/2001/XMLSchema#string

Takuya Yamamoto

http://www.w3.org/2001/XMLSchema#string

Toru Miyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system

DNAse footprinting: a simple method for the detection of protein-DNA binding specificity

Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis

Exonuclease III protection assay with FRET probe for detecting DNA-binding proteins

Inactivation of NF-kappaB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

Transcription factors as potential targets for therapeutic drugs.

Transcription factors as targets for cancer therapy.

A histone octamer blocks branch migration of a Holliday junction.

P304

870-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12420

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261606162

http://www.w3.org/2001/XMLSchema#string

P698

24724610

http://www.w3.org/2001/XMLSchema#string

P921

P932

4317927

http://www.w3.org/2001/XMLSchema#string